viking therapeutics vk2735 - Search News

News

Viking Therapeutics stock tumbles 37% today

The Motley Fool on MSN · 40m

Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip?

Viking Therapeutics (VKTX 5.71%) fell a whopping 39.2% from their previous close on Tuesday, Aug. 19. Investors were reacting to new clinical trial result

Viking Therapeutics: What's Happening With VKTX Stock?

The oral formulation led to up to 12.2% weight loss over three months, a weaker outcome versus late-stage treatments from Eli Lilly and Novo Nordisk.

Invezz on MSN · 1d

Viking Therapeutics stock tumbles 37% today, but here’s why you should ‘HOLD’

Viking Therapeutics stock plunges 37% as trial data sparks concerns over dropout rates and side effects despite weight loss gains.

Viking Therapeutics, Mixed Data and Obesity Pill Study

Zacks.com on MSN · 17h

Viking Therapeutics' Stock Tanks on Mixed Data From Obesity Pill Study

Shares of Viking Therapeutics VKTX plunged 42% yesterday after it reported top-line data from the phase II VENTURE-Oral Dosing study, which evaluated the safety and efficacy of the oral formulation of its experimental obesity drug, VK2735.

Reuters on MSN · 1d

Viking's weight-loss pill data disappoints, shares sink

Viking Therapeutics said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a mid-stage trial, missing Wall Street's top-end expectations of 15% and sending its shares plummeting by 41%.

Seeking Alpha on MSN · 1d

Viking Therapeutics plunges after mid-stage trial data for oral weight loss drug

Viking Therapeutics (VKTX) stock drops even as a mid-stage trial for its oral weight loss drug VK2735 succeeds. Novo (NVO) and Eli Lilly (LLY) gain. Read more here.

18hon MSN

Here's Why Viking Therapeutics Bounced Back Today

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data ...

10h

Viking Therapeutics: Panic Creates Opportunity

Viking Therapeutics' stock drops 40% despite strong Phase 2 weight-loss drug results. See here to know why I remain ultra bullish on VKTX stock.

7h

Viking Therapeutics (VKTX) Slashes 42% on Huge Clinical Study Dropout Rate

We recently published 10 Stocks Hammered Harder Than Wall Street. Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of Tuesday’s ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results